Published in J Biomed Biotechnol on January 01, 2008
Human endogenous retroviral long terminal repeat sequences as cell type-specific promoters in retroviral vectors. J Virol (2009) 0.88
Magnetic field-controlled gene expression in encapsulated cells. J Control Release (2011) 0.83
Cross-packaging of genetically distinct mouse and primate retroviral RNAs. Retrovirology (2009) 0.82
Sequences within both the 5' UTR and Gag are required for optimal in vivo packaging and propagation of mouse mammary tumor virus (MMTV) genomic RNA. PLoS One (2012) 0.80
Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell (1984) 6.71
Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res (1997) 4.89
Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer (1979) 3.37
Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro (1974) 2.93
Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res (1988) 2.28
GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Res (2002) 1.77
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol (2005) 1.77
Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res (1993) 1.73
Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res (2002) 1.48
Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Adv Exp Med Biol (1999) 1.18
Glucocorticoid regulation of mouse mammary tumor virus sequences in transgenic mice. Proc Natl Acad Sci U S A (1985) 1.17
Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. Cancer Res (2003) 1.13
Prolactin regulation of mouse mammary tumor virus (MMTV) expression in normal mouse mammary epithelium. Mol Cell Endocrinol (1989) 1.07
Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet (2001) 1.06
Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment. Eur J Cancer (2005) 1.01
Mouse models for breast cancer. Breast Cancer Res (1999) 1.00
WPRE-mediated enhancement of gene expression is promoter and cell line specific. Gene (2006) 0.98
Targeting of retroviral vectors for gene therapy. Hum Gene Ther (1993) 0.97
Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy. Cancer Res (1995) 0.96
Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation. Cancer Res (1989) 0.96
Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm. Clin Cancer Res (1995) 0.91
Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: results of a phase I/II clinical trial. J Gastroenterol (2003) 0.90
Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene. Cancer Res (1996) 0.85
Mouse mammary tumor virus production stimulated by hormones and polyamines in cells grown in semi-synthetic in vitro conditions. Int J Cancer (1977) 0.85
Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450. Gene Ther (1998) 0.84
Specific packaging of spliced retroviral vector transcripts lacking the Psi-region. Biochem Biophys Res Commun (2002) 0.83
Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks. Curr Opin Mol Ther (2001) 0.82
Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vector. Mol Ther (2001) 0.82
Gene-directed enzyme prodrug therapy: a current assessment. Curr Opin Mol Ther (2004) 0.81
Characterization of a human cell clone expressing cytochrome P450 for safe use in human somatic cell therapy. Ann N Y Acad Sci (1999) 0.81
Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements. J Virol (2004) 0.81
Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine. Cancer Gene Ther (2000) 0.79
Encapsulated cells producing retroviral vectors for in vivo gene transfer. J Gene Med (2002) 0.79
Analysis of 4-hydroxycyclophosphamide in human blood. Anal Biochem (1995) 0.79
Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma. Eur J Surg Oncol (2003) 0.78
Retroviral packaging cells encapsulated in TheraCyte immunoisolation devices enable long-term in vivo gene delivery. Front Biosci (2003) 0.77
Mouse mammary tumor virus infects human cells. Cancer Res (2005) 1.51
Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nat Methods (2010) 1.48
Viruses and human breast cancer. Future Microbiol (2006) 1.35
A novel, mouse mammary tumor virus encoded protein with Rev-like properties. Virology (2005) 1.35
Mouse mammary tumor virus integration site selection in human and mouse genomes. J Virol (2007) 1.27
Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy. Int J Cancer (2008) 1.17
Generation and characterization of immortalized rat pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol (2004) 1.15
Rapid spread of mouse mammary tumor virus in cultured human breast cells. Retrovirology (2007) 1.13
myo-Inositol and sucrose concentrations affect the accumulation of raffinose family oligosaccharides in seeds. J Exp Bot (2004) 1.08
FMDV-2A sequence and protein arrangement contribute to functionality of CYP2B1-reporter fusion protein. Anal Biochem (2005) 1.06
A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies. J Infect Dis (2011) 1.06
Unique features of different members of the human guanylate-binding protein family. J Interferon Cytokine Res (2007) 1.02
The metabolic role and evolution of L-arabinitol 4-dehydrogenase of Hypocrea jecorina. Eur J Biochem (2004) 1.02
GBP-1 acts as a tumor suppressor in colorectal cancer cells. Carcinogenesis (2012) 1.01
Mouse mammary tumor virus-like sequences in human breast cancer. Cancer Res (2010) 1.01
WPRE-mediated enhancement of gene expression is promoter and cell line specific. Gene (2006) 0.98
Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression. FASEB J (2008) 0.96
Proliferation of aligned mammalian cells on laser-nanostructured polystyrene. Biomaterials (2008) 0.94
Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma. J Neurooncol (2010) 0.94
Identification of the Rem-responsive element of mouse mammary tumor virus. Nucleic Acids Res (2008) 0.92
Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells. Chem Res Toxicol (2007) 0.92
Oesophagostomum dentatum extract modulates T cell-dependent immune responses to bystander antigens and prevents the development of allergy in mice. PLoS One (2013) 0.91
Coupled and independent contributions of residues in IS6 and IIS6 to activation gating of CaV1.2. J Biol Chem (2009) 0.90
Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. Mol Med (2010) 0.90
Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: results of a phase I/II clinical trial. J Gastroenterol (2003) 0.90
Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors. J Virol (2006) 0.88
The cytotoxic activity of the bacteriophage lambda-holin protein reduces tumour growth rates in mammary cancer cell xenograft models. J Gene Med (2006) 0.88
Human endogenous retroviral long terminal repeat sequences as cell type-specific promoters in retroviral vectors. J Virol (2009) 0.88
Association of glycosylphosphatidylinositol-anchored protein with retroviral particles. FASEB J (2008) 0.87
Molecularly characterised xenograft tumour mouse models: valuable tools for evaluation of new therapeutic strategies for secondary liver cancers. J Biomed Biotechnol (2009) 0.87
Stachyose in the cytosol does not influence freezing tolerance of transgenic Arabidopsis expressing stachyose synthase from adzuki bean. Plant Sci (2010) 0.87
Inhibition of raffinose oligosaccharide breakdown delays germination of pea seeds. J Plant Physiol (2007) 0.86
Enhancement of the StreptoTag method for isolation of endogenously expressed proteins with complex RNA binding targets. Electrophoresis (2006) 0.86
Rafts, anchors and viruses--a role for glycosylphosphatidylinositol anchored proteins in the modification of enveloped viruses and viral vectors. Virology (2008) 0.86
Bacteriophage-encoded toxins: the lambda-holin protein causes caspase-independent non-apoptotic cell death of eukaryotic cells. Cell Microbiol (2007) 0.85
Oesophagostomum dentatum: potential as a model for genomic studies of strongylid nematodes, with biotechnological prospects. Biotechnol Adv (2007) 0.83
Magnetic field-controlled gene expression in encapsulated cells. J Control Release (2011) 0.83
Specific packaging of spliced retroviral vector transcripts lacking the Psi-region. Biochem Biophys Res Commun (2002) 0.83
Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors. Virology (2005) 0.82
Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century. Cancer Chemother Pharmacol (2002) 0.82
Encapsulated, genetically modified cells producing in vivo therapeutics. Curr Opin Mol Ther (2004) 0.82
Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer. PLoS One (2012) 0.82
Mutations in the catalytic core or the C-terminus of murine leukemia virus (MLV) integrase disrupt virion infectivity and exert diverse effects on reverse transcription. Virology (2007) 0.81
Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements. J Virol (2004) 0.81
Promoter complex in the central part of the mouse mammary tumor virus long terminal repeat. J Virol (2007) 0.80
Effects of sequences of prokaryotic origin on titer and transgene expression in retroviral vectors. Virology (2004) 0.80
Novel treatments and therapies in development for pancreatic cancer. Expert Opin Investig Drugs (2002) 0.79
Encapsulated cells producing retroviral vectors for in vivo gene transfer. J Gene Med (2002) 0.79
Age, not infection dose, determines the outcome of Isospora suis infections in suckling piglets. Parasitol Res (2009) 0.79
Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors. BMC Mol Biol (2009) 0.78
Mouse mammary tumor-like virus and human breast cancer. Breast Cancer Res Treat (2010) 0.78
The murine whey acidic protein promoter directs expression to human mammary tumors after retroviral transduction. Cancer Gene Ther (2002) 0.78
HIV-1 Rev can specifically interact with MMTV RNA and upregulate gene expression. Gene (2005) 0.78
A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study. J Mol Med (Berl) (2002) 0.78
Intra-arterial instillation of microencapsulated, Ifosfamide-activating cells in the pig pancreas for chemotherapeutic targeting. Pancreatology (2003) 0.78
Enzymatic breakdown of raffinose oligosaccharides in pea seeds. Planta (2008) 0.78